Cullinan Therapeutics IncNASDAQ:CGEM
- LAST PRICE18.0600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots17.8200/ 60
- Ask / Lots19.9900/ 3
- Open / Previous Close0.0000 / 18.0600
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CGEM |
|---|---|---|
| 09:32 ET | 4570 | 18 |
| 09:34 ET | 347 | 18.335 |
| 09:36 ET | 600 | 18.39 |
| 09:38 ET | 4761 | 18.62 |
| 09:39 ET | 9341 | 18.86 |
| 09:41 ET | 9091 | 19.07 |
| 09:43 ET | 1900 | 19.07 |
| 09:45 ET | 3195 | 19.01 |
| 09:48 ET | 1000 | 19.01 |
| 09:50 ET | 4000 | 18.885 |
| 09:52 ET | 8550 | 18.94 |
| 09:54 ET | 5178 | 18.925 |
| 09:56 ET | 4633 | 18.985 |
| 09:57 ET | 5729 | 18.97 |
| 09:59 ET | 4868 | 18.95 |
| 10:01 ET | 13030 | 18.98 |
| 10:03 ET | 2899 | 19 |
| 10:06 ET | 9259 | 19.05 |
| 10:08 ET | 2390 | 19 |
| 10:10 ET | 2028 | 19.005 |
| 10:14 ET | 2800 | 18.82 |
| 10:15 ET | 7362 | 18.94 |
| 10:17 ET | 7975 | 19 |
| 10:19 ET | 8140 | 18.895 |
| 10:24 ET | 12305 | 19.0185 |
| 10:26 ET | 300 | 18.99 |
| 10:28 ET | 11402 | 19.04 |
| 10:30 ET | 1508 | 19.09 |
| 10:32 ET | 1529 | 19 |
| 10:33 ET | 6063 | 18.97 |
| 10:35 ET | 6023 | 19 |
| 10:37 ET | 300 | 18.995 |
| 10:39 ET | 4336 | 19.06 |
| 10:42 ET | 403 | 19.01 |
| 10:44 ET | 1500 | 19 |
| 10:46 ET | 2740 | 18.96 |
| 10:48 ET | 900 | 18.96 |
| 10:50 ET | 2864 | 18.97 |
| 10:51 ET | 2500 | 18.8 |
| 10:53 ET | 1310 | 18.725 |
| 10:55 ET | 119 | 18.77 |
| 10:57 ET | 4630 | 18.9 |
| 11:00 ET | 1100 | 18.9 |
| 11:02 ET | 800 | 18.97 |
| 11:06 ET | 3835 | 18.985 |
| 11:08 ET | 305 | 18.985 |
| 11:09 ET | 1300 | 19.0199 |
| 11:11 ET | 3929 | 18.985 |
| 11:13 ET | 4627 | 18.895 |
| 11:15 ET | 200 | 18.92 |
| 11:18 ET | 300 | 18.94 |
| 11:22 ET | 3000 | 18.92 |
| 11:24 ET | 390 | 18.89 |
| 11:26 ET | 1290 | 18.87 |
| 11:27 ET | 3445 | 19 |
| 11:29 ET | 600 | 18.97 |
| 11:31 ET | 900 | 18.89 |
| 11:33 ET | 100 | 18.9 |
| 11:36 ET | 100 | 18.82 |
| 11:38 ET | 200 | 18.82 |
| 11:40 ET | 4030 | 18.66 |
| 11:42 ET | 313 | 18.64 |
| 11:44 ET | 300 | 18.545 |
| 11:45 ET | 1382 | 18.67 |
| 11:47 ET | 300 | 18.655 |
| 11:49 ET | 100 | 18.63 |
| 11:51 ET | 200 | 18.68 |
| 11:56 ET | 2200 | 18.555 |
| 11:58 ET | 100 | 18.405 |
| 12:00 ET | 100 | 18.335 |
| 12:02 ET | 700 | 18.24 |
| 12:03 ET | 300 | 18.24 |
| 12:05 ET | 1700 | 18.385 |
| 12:07 ET | 586 | 18.415 |
| 12:09 ET | 300 | 18.34 |
| 12:12 ET | 900 | 18.34 |
| 12:14 ET | 2770 | 18.405 |
| 12:16 ET | 200 | 18.405 |
| 12:20 ET | 500 | 18.45 |
| 12:21 ET | 700 | 18.4306 |
| 12:23 ET | 1058 | 18.4 |
| 12:25 ET | 600 | 18.375 |
| 12:27 ET | 100 | 18.355 |
| 12:30 ET | 100 | 18.3 |
| 12:32 ET | 1200 | 18.31 |
| 12:34 ET | 700 | 18.31 |
| 12:36 ET | 1527 | 18.2 |
| 12:38 ET | 1497 | 18.15 |
| 12:39 ET | 200 | 18.14 |
| 12:41 ET | 867 | 18.24 |
| 12:43 ET | 500 | 18.12 |
| 12:45 ET | 1537 | 18.175 |
| 12:48 ET | 453 | 18.26 |
| 12:50 ET | 1616 | 18.36 |
| 12:52 ET | 1029 | 18.31 |
| 12:54 ET | 487 | 18.37 |
| 12:56 ET | 200 | 18.355 |
| 01:01 ET | 300 | 18.33 |
| 01:03 ET | 500 | 18.36 |
| 01:06 ET | 400 | 18.32 |
| 01:08 ET | 740 | 18.3775 |
| 01:10 ET | 594 | 18.36 |
| 01:12 ET | 3005 | 18.26 |
| 01:14 ET | 100 | 18.22 |
| 01:15 ET | 200 | 18.17 |
| 01:17 ET | 246 | 18.09 |
| 01:21 ET | 2118 | 18.15 |
| 01:24 ET | 1769 | 18.16 |
| 01:26 ET | 1000 | 18.15 |
| 01:28 ET | 207 | 18.19 |
| 01:30 ET | 200 | 18.17 |
| 01:32 ET | 500 | 18.13 |
| 01:35 ET | 700 | 18.1 |
| 01:37 ET | 800 | 18.09 |
| 01:39 ET | 100 | 18.05 |
| 01:42 ET | 2663 | 18.185 |
| 01:44 ET | 100 | 18.22 |
| 01:46 ET | 300 | 18.245 |
| 01:48 ET | 461 | 18.2 |
| 01:50 ET | 100 | 18.2 |
| 01:51 ET | 1700 | 18.195 |
| 01:53 ET | 700 | 18.18 |
| 01:55 ET | 272 | 18.1201 |
| 01:57 ET | 900 | 18.13 |
| 02:00 ET | 1799 | 18.2 |
| 02:02 ET | 100 | 18.22 |
| 02:04 ET | 700 | 18.16 |
| 02:08 ET | 272 | 18.11 |
| 02:09 ET | 300 | 18.08 |
| 02:11 ET | 600 | 18.06 |
| 02:13 ET | 800 | 18.06 |
| 02:15 ET | 532 | 18.105 |
| 02:18 ET | 2016 | 18.09 |
| 02:20 ET | 300 | 18.12 |
| 02:22 ET | 100 | 18.11 |
| 02:26 ET | 200 | 18.115 |
| 02:27 ET | 1732 | 18.22 |
| 02:29 ET | 1700 | 18.1 |
| 02:31 ET | 100 | 18.13 |
| 02:33 ET | 1539 | 18.08 |
| 02:36 ET | 300 | 18.06 |
| 02:38 ET | 100 | 18.02 |
| 02:40 ET | 3136 | 18.04 |
| 02:42 ET | 3007 | 18.13 |
| 02:44 ET | 500 | 18.13 |
| 02:45 ET | 9398 | 18.18 |
| 02:47 ET | 2618 | 18.19 |
| 02:49 ET | 4219 | 18.22 |
| 02:51 ET | 1400 | 18.23 |
| 02:54 ET | 2983 | 18.21 |
| 02:56 ET | 424 | 18.21 |
| 02:58 ET | 700 | 18.1399 |
| 03:00 ET | 618 | 18.06 |
| 03:02 ET | 863 | 18.0675 |
| 03:03 ET | 1180 | 18.07 |
| 03:05 ET | 1523 | 18.1 |
| 03:07 ET | 4575 | 18.09 |
| 03:09 ET | 3200 | 18.0501 |
| 03:12 ET | 1746 | 18.22 |
| 03:14 ET | 2200 | 18.19 |
| 03:16 ET | 3389 | 18.22 |
| 03:18 ET | 2100 | 18.215 |
| 03:20 ET | 2298 | 18.12 |
| 03:21 ET | 800 | 18.06 |
| 03:23 ET | 2136 | 18.13 |
| 03:25 ET | 800 | 18.09 |
| 03:27 ET | 200 | 18.08 |
| 03:30 ET | 1442 | 18.13 |
| 03:32 ET | 2299 | 18.05 |
| 03:34 ET | 700 | 17.99 |
| 03:36 ET | 1819 | 18.04 |
| 03:38 ET | 1957 | 17.99 |
| 03:39 ET | 1015 | 17.98 |
| 03:41 ET | 3972 | 18.04 |
| 03:43 ET | 6919 | 18.05 |
| 03:45 ET | 8317 | 18.16 |
| 03:48 ET | 6509 | 18.155 |
| 03:50 ET | 443 | 18.155 |
| 03:52 ET | 4940 | 18.03 |
| 03:54 ET | 11401 | 18.1 |
| 03:56 ET | 6910 | 18.11 |
| 03:57 ET | 19600 | 18.05 |
| 03:59 ET | 21312 | 18.06 |
Yesterday
DJ Cullinan Oncology Is Maintained at Buy by JonesTrading, from 7:07AM ET on Thursday Apr 18, 2024 by Dow Jones
7:07AM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 17, 2024
DJ Cullinan Oncology Is Maintained at Buy by BTIG, from 11:31AM ET on Wednesday Apr 17, 2024 by Dow Jones
11:31AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 16, 2024
DJ Cullinan Oncology Is Maintained at Buy by HC Wainwright & Co., from 1:04PM ET on Tuesday Apr 16, 2024 by Dow Jones
1:04PM ET on Tuesday Apr 16, 2024 by Dow JonesDJ Cullinan Oncology Shares Jump 21% on Planned Autoimmune Diseases Expansion, Private Placement, from 8:09AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:09AM ET on Tuesday Apr 16, 2024 by Dow JonesCullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases, from 7:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cullinan Therapeutics Inc | 777.8M | -4.9x | --- |
Tyra Biosciences Inc | 770.0M | -9.1x | --- |
ALX Oncology Holdings Inc | 789.4M | -4.2x | --- |
Praxis Precision Medicines Inc | 771.4M | -2.0x | --- |
CARGO Therapeutics Inc | 751.8M | -8.1x | --- |
Disc Medicine Inc | 740.9M | -8.6x | --- |
Company Information
Cullinan Therapeutics, Inc., formerly Cullinan Oncology, Inc., is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. It has a portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its pipeline includes CLN-619, CLN-978, Zipalertinib (CLN-081/TAS6417), CLN-049, CLN-418, and CLN-617. Its lead unpartnered program, CLN-619, is a humanized lgG1 monoclonal antibody (mAb) that binds to the stress induced ligands MICA and MICB (MICA/B), which are expressed on a variety of solid tumors and hematologic malignancies. CLN-978 is a novel, highly potent, half-life extended CD19xCD3 bispecific T cell engager construct. CLN-081/TAS6417 is a novel, orally available, covalent inhibitor of mutant epidermal growth factor receptor (EGFR). CLN-049 is a FLT3xCD3 T cell engaging bispecific antibody. CLN-418 is a B7H4 x 4-1BB bispecific immune activator.
Contact Information
- Headquarters
- One Main Street, Suite 1350CAMBRIDGE, MA, United States 02142
- Phone
- 617-410-4650
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Anthony Rosenberg
- President, Chief Executive Officer, Director
- Nadim Ahmed
- Chief Financial Officer, Treasurer
- Jeffrey Trigilio
- Chief Legal and Compliance Officer, Company Secretary
- Jacquelyn Sumer
- Chief Medical Officer
- Jeffrey Jones
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $777.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 43.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.70 |
Book Value | $10.58 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
